Pfizer-BioNTech calls its COVID-19 vaccine "Comirnaty," which was designed to be a combination of the phrases "Covid-19 immunity" + "mRNA" into a word that sounds like "Community." Do you think "Comirnaty" is a good name for the Pfizer-BioNTech vaccine, or not?

Pfizer‑BioNTech calls its COVID-19 vaccine "Comirnaty," which was designed to be a combination of the phrases "Covid-19 immunity" + "mRNA" into a word that sounds like "Community." Do you think "Comirnaty" is a good name for the Pfizer-BioNTech vaccine, or not? Published on August 26, 2021 → Survey conducted on August 26, 2021 on 8302 U.S. adults

All adults

Region

Gender

Politics

Age

It is a good name

17%

It is not a good name

55%

Don't know

28%

It is a good name

17%

It is not a good name

55%

Don't know

28%

Select a country

Highlights

By category

By type

Audience intelligence

Brand tracking & measurement

Run surveys and research

Shopper insights

Audience intelligence

Brand tracking

Quantitative research

Qualitative research

Why YouGov

About YouGov

Resources

Support

Select a country

Menu

65% of Americans support vaccine requirements for K-12 schools

Trump's job approval, immigration and assimilation, vaccines, and more: August 7 - 10, 2026 Economist/YouGov Poll

Has UnitedHealthcare’s brand health recovered?

Over the last three months, 8% of Americans first turned to AI for health information or advice

What factors do Americans consider when choosing medical treatments?

How Halodoc strengthened its market position in a post-COVID Indonesia with YouGov

Forever young? U.S. anti-aging report 2026

Spring allergy season is underway and it’s reshaping the OTC aisle

Brand pain points: Tracking Tylenol’s consumer performance through a turbulent year